167 related articles for article (PubMed ID: 26549033)
1. DNA methylation reactivates GAD1 expression in cancer by preventing CTCF-mediated polycomb repressive complex 2 recruitment.
Yan H; Tang G; Wang H; Hao L; He T; Sun X; Ting AH; Deng A; Sun S
Oncogene; 2016 Jul; 35(30):3995-4008. PubMed ID: 26549033
[TBL] [Abstract][Full Text] [Related]
2. CTCF regulates allelic expression of Igf2 by orchestrating a promoter-polycomb repressive complex 2 intrachromosomal loop.
Li T; Hu JF; Qiu X; Ling J; Chen H; Wang S; Hou A; Vu TH; Hoffman AR
Mol Cell Biol; 2008 Oct; 28(20):6473-82. PubMed ID: 18662993
[TBL] [Abstract][Full Text] [Related]
3. Promoter histone H3K27 methylation in the control of IGF2 imprinting in human tumor cell lines.
Li T; Chen H; Li W; Cui J; Wang G; Hu X; Hoffman AR; Hu J
Hum Mol Genet; 2014 Jan; 23(1):117-28. PubMed ID: 23962719
[TBL] [Abstract][Full Text] [Related]
4. Polycomb repressive complex 2 epigenomic signature defines age-associated hypermethylation and gene expression changes.
Dozmorov MG
Epigenetics; 2015; 10(6):484-95. PubMed ID: 25880792
[TBL] [Abstract][Full Text] [Related]
5. Interruption of intrachromosomal looping by CCCTC binding factor decoy proteins abrogates genomic imprinting of human insulin-like growth factor II.
Zhang H; Niu B; Hu JF; Ge S; Wang H; Li T; Ling J; Steelman BN; Qian G; Hoffman AR
J Cell Biol; 2011 May; 193(3):475-87. PubMed ID: 21536749
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of CTCF reduces the binding of EZH2 and affects the methylation of the SOCS3 promoter in hepatocellular carcinoma.
Wei L; Liu Q; Huang Y; Liu Z; Zhao R; Li B; Zhang J; Sun C; Gao B; Ding X; Yu X; He J; Sun A; Qin Y
Int J Biochem Cell Biol; 2020 Mar; 120():105685. PubMed ID: 31917284
[TBL] [Abstract][Full Text] [Related]
7. Restoration of IGF2 imprinting by polycomb repressive complex 2 docking factor SUZ12 in colon cancer cells.
Wang H; Ge S; Qian G; Li W; Cui J; Wang G; Hoffman AR; Hu JF
Exp Cell Res; 2015 Nov; 338(2):214-21. PubMed ID: 26407907
[TBL] [Abstract][Full Text] [Related]
8. Gain of DNA methylation is enhanced in the absence of CTCF at the human retinoblastoma gene promoter.
Dávalos-Salas M; Furlan-Magaril M; González-Buendía E; Valdes-Quezada C; Ayala-Ortega E; Recillas-Targa F
BMC Cancer; 2011 Jun; 11():232. PubMed ID: 21663659
[TBL] [Abstract][Full Text] [Related]
9. CTCF controls HOXA cluster silencing and mediates PRC2-repressive higher-order chromatin structure in NT2/D1 cells.
Xu M; Zhao GN; Lv X; Liu G; Wang LY; Hao DL; Wang J; Liu DP; Liang CC
Mol Cell Biol; 2014 Oct; 34(20):3867-79. PubMed ID: 25135475
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic repression of RARRES1 is mediated by methylation of a proximal promoter and a loss of CTCF binding.
Peng Z; Shen R; Li YW; Teng KY; Shapiro CL; Lin HJ
PLoS One; 2012; 7(5):e36891. PubMed ID: 22615834
[TBL] [Abstract][Full Text] [Related]
11. GAD1 mRNA expression and DNA methylation in prefrontal cortex of subjects with schizophrenia.
Huang HS; Akbarian S
PLoS One; 2007 Aug; 2(8):e809. PubMed ID: 17726539
[TBL] [Abstract][Full Text] [Related]
12. Maternal care and DNA methylation of a glutamic acid decarboxylase 1 promoter in rat hippocampus.
Zhang TY; Hellstrom IC; Bagot RC; Wen X; Diorio J; Meaney MJ
J Neurosci; 2010 Sep; 30(39):13130-7. PubMed ID: 20881131
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the GAD1 promoter: trans-acting factors and DNA methylation converge on the 5' untranslated region.
Chen Y; Dong E; Grayson DR
Neuropharmacology; 2011 Jun; 60(7-8):1075-87. PubMed ID: 20869372
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation reactivates GAD1 expression in cancer by preventing CTCF-mediated polycomb repressive complex 2 recruitment.
Yan H; Tang G; Wang H; Hao L; He T; Sun X; Ting AH; Deng A; Sun S
Oncogene; 2016 Jul; 35(30):4020. PubMed ID: 27345404
[No Abstract] [Full Text] [Related]
15. Disruption of CTCF/cohesin-mediated high-order chromatin structures by DNA methylation downregulates PTGS2 expression.
Kang JY; Song SH; Yun J; Jeon MS; Kim HP; Han SW; Kim TY
Oncogene; 2015 Nov; 34(45):5677-84. PubMed ID: 25703332
[TBL] [Abstract][Full Text] [Related]
16. The promoter methylation status and mRNA expression levels of CTCF and SIRT6 in sporadic breast cancer.
Wang D; Li C; Zhang X
DNA Cell Biol; 2014 Sep; 33(9):581-90. PubMed ID: 24842653
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr Virus Rta-Mediated Accumulation of DNA Methylation Interferes with CTCF Binding in both Host and Viral Genomes.
Chen YJ; Chen YL; Chang Y; Wu CC; Ko YC; Tsao SW; Chen JY; Lin SF
J Virol; 2017 Aug; 91(15):. PubMed ID: 28490592
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic signature of panic disorder: a role of glutamate decarboxylase 1 (GAD1) DNA hypomethylation?
Domschke K; Tidow N; Schrempf M; Schwarte K; Klauke B; Reif A; Kersting A; Arolt V; Zwanzger P; Deckert J
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():189-96. PubMed ID: 23906988
[TBL] [Abstract][Full Text] [Related]
19. GAD1 alternative transcripts and DNA methylation in human prefrontal cortex and hippocampus in brain development, schizophrenia.
Tao R; Davis KN; Li C; Shin JH; Gao Y; Jaffe AE; Gondré-Lewis MC; Weinberger DR; Kleinman JE; Hyde TM
Mol Psychiatry; 2018 Jun; 23(6):1496-1505. PubMed ID: 28485403
[TBL] [Abstract][Full Text] [Related]
20. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
